Principal component analysis of CYP2C9 and CYP3A4 probe substrate/inhibitor panels

Drug Metabolism and Disposition

Volumn 36, Issue 11, 2008, Pages 2151-2155

  Nath, Abhinav ^a   Atkins, William ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; BUDESONIDE; CAFFEINE; CISAPRIDE; CLOTRIMAZOLE; CLOZAPINE; CYCLOSPORIN; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DIAZEPAM; DIGITOXIN; DISOPYRAMIDE; ERYTHROMYCIN; ETHIONAMIDE; FLUCONAZOLE; GENTAMICIN; HALOPERIDOL; IBUPROFEN; ITRACONAZOLE; KETOCONAZOLE; METOCLOPRAMIDE; METRONIDAZOLE; NIFEDIPINE; NIMODIPINE; NITRENDIPINE; PHENACETIN; PHENYTOIN; PROPOFOL; UNINDEXED DRUG;

ARTICLE; CLUSTER ANALYSIS; CORRELATION COEFFICIENT; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; INHIBITION KINETICS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; ENZYME INHIBITORS; MOLECULAR PROBES; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; SUBSTRATE SPECIFICITY;

EID: 54349107419     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.022061     Document Type: Article

References (8)

1. Atkins WM (2006) Current views on the fundamental mechanisms of cytochrome P450 allosterism. Expert Opin Drug Metab Toxicol 2:573-579.
2. Bloom JD, Romero PA, Lu Z, and Arnold FH (2007) Neutral genetic drift can alter promiscuous protein functions, potentially aiding functional evolution. Biol Direct 2:17.
3. Foti RS and Wahlstrom JL (2008) CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles. Drug Metab Dispos 36:523-528.
4. Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611-650.
5. Kenworthy KE, Bloomer JC, Clarke SE, and Houston JB (1999) CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br J Clin Pharmacol 48:716-727.
6. Kumar V, Wahlstrom JL, Rock DA, Warren CJ, Gorman LA, and Tracy TS (2006) CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles. Drug Metab Dispos 34:1966-1975.
7. Nath A and Atkins WM (2008) A quantitative index of substrate promiscuity. Biochemistry 47:157-166.
8. Wall ME, Rechtsteiner A, and Rocha LM (2003) Singular value decomposition and principal component analysis, in A Practical Approach to Microarray Data Analysis (Berrar DP, Dubitzky W, and Granzow M eds), pp 91-109, Kluwer, Norwell, MA.